References
- Berghoff M, Kathpal M, Khan F, et al. (2003). Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol 53:725–30
- Chiti F, Webster P, Taddei N, et al. (1999). Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 96:3590–4
- Dispenzieri A, Kyle RA, Lacy MQ, et al. (2004). Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 103:3960–3
- Falk RH. (2005). Diagnosis and management of the cardiac amyloidoses. Circulation 112:2047–60
- Franco DA, Truran S, Burciu C, et al. (2012). Protective role of clusterin in preserving endothelial function in AL amyloidosis. Atherosclerosis 225:220–3
- Gobbi M, Re F, Canovi M, et al. (2010). Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. Biomaterials 31:6519–29
- Lasch J, Weissig V, Brandl M. (2003). Preparation of liposomes. In Torchilin VP, Weissig V, eds. Liposomes. Oxford: Oxford University Press; 3--27
- Levinson RT, Olatoye OO, Randles EG, et al. (2013). Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes. Sci Rep 3:1278 . doi: 10.1038/srep01278
- McLaughlin RW, De Stigter JK, Sikkink LA, et al. (2006). The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light chain protein. Protein Sci 15:1710–22
- Meng X, Fink AL, Uversky VN. (2008). The effect of membranes on the in vitro fibrillation of an amyloidogenic light chain variable-domain SMA. J Mol Biol 381:989–99
- Migrino RQ, Hari P, Gutterman DD, et al. (2010). Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 145:67–8
- Migrino RQ, Mareedu RK, Eastwood D, et al. (2009). Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis. J Am Soc Echocardiogr 22:1396–402
- Migrino RQ, Truran S, Gutterman DD, et al. (2011). Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol 301:H2305–12
- Modesto KM, Dispenzieri A, Gertz M, et al. (2007). Vascular abnormalities in primary amyloidosis. Eur Heart J 28:1019–24
- Re F, Cambianica I, Sesana S, et al. (2011). Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. J Biotechnol 156:341–6
- Solomon A, Weiss DT, Wall JS. (2003). Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. Clin Cancer Res 9:3831S–8S